Saturday, 5 December 2020

UK, Germany Start Trials of COVID-19 Vaccine

Reuters

BERLIN: The race to develop an effective vaccine against the novel coronavirus gathered pace this week, as clinical trials on humans were approved in Germany and launched in the UK.

Though there are now around 150 development projects worldwide, the German and British plans are among only five clinical trials on humans which have been approved across the globe.

In Britain, volunteers in a trial at the University of Oxford are set to be given on Thursday the first dose of a potential vaccine based on a virus found in chimpanzees.

Meanwhile on Wednesday, German regulatory body PEI green-lighted the country’s first trials on human volunteers for a vaccine developed by Ger­man firm Biontech and US giant Pfizer.

The Oxford trial, run by the university’s Jenner Institute, will involve 510 volunteers aged between 18 and 55 in the first phase.

Research director Professor Sarah Gilbert estimated that it has around an 80 percent chance of being successful.

The institute aims to develop a million doses of the vaccine by September, so as to distribute it as quickly as possible after approval.

The Oxford trial is part of a nationwide effort in the UK which since Friday has been spearheaded by a government taskforce.

Check Also

England now No.1 ranked team in T20I cricket

CAPE TOWN: England have displaced Australia from the numero uno spot in ICC T20I rankings ...

Leave a Reply